To determine if BDNF signaling is intact and BDNF supplementation could represent a possible therapeutic avenue for DM1, first we examined the levels of BDNF in EpA960/CaMKII-Cre mouse brains. The gene discussed is BDNF; the disease is myotonic dystrophy type 1.